Related Experiment Video
Updated: Mar 7, 2026
06:46
Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
Published on: January 9, 2026
232
Lymphadenectomy in elderly/high risk patients: should it be different?
Laura Ruspi1, Federica Galli1, Vincenzo Pappalardo1
1Department of General Surgery, University of Insubria, 21100 Varese, Italy; Department of Surgical Sciences, University of Insubria, 21100 Varese, Italy.
Translational Gastroenterology and Hepatology
|February 21, 2017
Summary
Elderly patients undergoing gastric cancer surgery require personalized treatment. Tailoring surgical approaches based on age and comorbidities, not just cancer stage, may improve outcomes for this growing patient group.
Area of Science:
- Oncology
- Geriatric Surgery
- Surgical Oncology
Background:
- Global population aging increases the number of elderly patients requiring surgical procedures.
- Gastric cancer treatment, particularly lymphadenectomy, has established survival benefits in randomized controlled trials (RCTs).
- Extended lymphadenectomy is the gold standard for non-early gastric tumors.
Purpose of the Study:
- To evaluate the prognostic significance of age in gastric cancer patients.
- To determine the benefits of extended surgery in elderly or high-risk gastric cancer patients.
- To explore the potential for tailoring gastric cancer surgery based on patient age and comorbidities.
Main Methods:
- Literature review of studies concerning gastric cancer surgery in elderly and high-risk patients.
- Analysis of prognostic factors, including age and comorbidities.
- Assessment of the impact of lymphadenectomy extent on survival in different patient groups.
Main Results:
- The prognostic role of age in gastric cancer requires further clarification.
- The specific benefits of extended surgery for elderly/high-risk patients are not well-defined.
- Current literature suggests a need for individualized surgical strategies.
Conclusions:
- Gastric cancer surgery may benefit from further personalization.
- Treatment decisions should consider not only disease stage but also patient age and comorbidities.
- Optimizing surgical care for the aging population is crucial.
